Blog
HairClone Developing Personalized Cell Replacement Therapies
Manchester, UK. 12/18 – Hairclone, is a startup company formed by a partnership of Scientists, Hair Transplant Surgeons and Patients to develop cutting-edge treatments for baldness. The most common type of hair loss is caused by hair follicles losing their regenerative abilities, causing them to miniaturize and create the appearance of thinning or balding. HairClone is developing a treatment to replace these lost cells. A few of a patient’s non-affected follicles will be harvested in a simple out-patient procedure. Potent cells will then be isolated from these fol-licles, multiplied in the laboratory, and micro-injected into the affected part of the scalp with the intention of rejuvenating the hair shafts, mak-ing them thicker and longer. Hairclone also plans to start the world’s first hair follicle bio-bank in 2019. Bio-banking will allow patients to store a small number of their hair follicles at the earliest age. These can be held in reserve and used for future hair loss treatments.
Related Posts
Autumn Shedding
The Thinning Hair Attachment Safety Guide
Whatever Happened to Hair Cloning?
When Hair Is Not Enough
New Hope for Teens Facing Sudden Hair Loss
What If You Could See the Future You?
Independent Hair News Source Joins Telehealth Brand
Cambridge Researchers Harnessing Cellular Energy
Hair, Health, and Hope
Hair Loss Tops Global Beauty Concerns
Stem Cells Discovery Sheds Light on Hair Regeneration
Leqselvi – FDA Approved for Severe Alopecia Areata
One thought on “HairClone Developing Personalized Cell Replacement Therapies”
Click here to cancel reply.
You must be logged in to post a comment.
Male and female patients who are concerned about hair loss can now have some of their hair follicles cryopreserved and stored for future available treatments.